132 related articles for article (PubMed ID: 33657653)
1. Predicting sentinel node positivity in patients with melanoma: external validation of a risk-prediction calculator (the Melanoma Institute Australia nomogram) using a large European population-based patient cohort.
El Sharouni MA; Varey AHR; Witkamp AJ; Ahmed T; Sigurdsson V; van Diest PJ; Scolyer RA; Thompson JF; Lo SN; van Gils CH
Br J Dermatol; 2021 Aug; 185(2):412-418. PubMed ID: 33657653
[TBL] [Abstract][Full Text] [Related]
2. Improved Risk Prediction Calculator for Sentinel Node Positivity in Patients With Melanoma: The Melanoma Institute Australia Nomogram.
Lo SN; Ma J; Scolyer RA; Haydu LE; Stretch JR; Saw RPM; Nieweg OE; Shannon KF; Spillane AJ; Ch'ng S; Mann GJ; Gershenwald JE; Thompson JF; Varey AHR
J Clin Oncol; 2020 Aug; 38(24):2719-2727. PubMed ID: 32530761
[TBL] [Abstract][Full Text] [Related]
3. Validation of a Nomogram for Non-sentinel Node Positivity in Melanoma Patients, and Its Clinical Implications: A Brazilian-Dutch Study.
Bertolli E; Franke V; Calsavara VF; de Macedo MP; Pinto CAL; van Houdt WJ; Wouters MWJM; Duprat Neto JP; van Akkooi ACJ
Ann Surg Oncol; 2019 Feb; 26(2):395-405. PubMed ID: 30456681
[TBL] [Abstract][Full Text] [Related]
4. Predicting recurrence in patients with sentinel node-negative melanoma: validation of the EORTC nomogram using population-based data.
El Sharouni MA; Ahmed T; Witkamp AJ; Sigurdsson V; van Gils CH; Nieweg OE; Scolyer RA; Thompson JF; van Diest PJ; Lo SN
Br J Surg; 2021 May; 108(5):550-553. PubMed ID: 34043770
[TBL] [Abstract][Full Text] [Related]
5. Validation of a nomogram predicting sentinel lymph node status in melanoma in an Irish population.
Woods JF; De Marchi JA; Lowery AJ; Hill AD
Ir J Med Sci; 2015 Dec; 184(4):769-73. PubMed ID: 24997756
[TBL] [Abstract][Full Text] [Related]
6. Validation of the Melanoma Institute of Australia's Sentinel Lymph Node Biopsy Risk Prediction Tool for Cutaneous Melanoma.
Maddineni S; Dizon MP; Muralidharan V; Young LA; Sunwoo JB; Baik FM; Swetter SM
Ann Surg Oncol; 2024 Apr; 31(4):2737-2746. PubMed ID: 38216800
[TBL] [Abstract][Full Text] [Related]
7. Population-Based Validation of the MIA and MSKCC Tools for Predicting Sentinel Lymph Node Status.
Olofsson Bagge R; Mikiver R; Marchetti MA; Lo SN; van Akkooi ACJ; Coit DG; Ingvar C; Isaksson K; Scolyer RA; Thompson JF; Varey AHR; Wong SL; Lyth J; Bartlett EK
JAMA Surg; 2024 Mar; 159(3):260-268. PubMed ID: 38198163
[TBL] [Abstract][Full Text] [Related]
8. Validation of a nomogram to predict the presence of sentinel lymph node metastases in melanoma.
Piñero A; Canteras M; Ortiz E; Martínez-Barba E; Parrilla P
Ann Surg Oncol; 2008 Oct; 15(10):2874-7. PubMed ID: 18648880
[TBL] [Abstract][Full Text] [Related]
9. The EORTC-DeCOG nomogram adequately predicts outcomes of patients with sentinel node-positive melanoma without the need for completion lymph node dissection.
Verver D; Rekkas A; Garbe C; van Klaveren D; van Akkooi ACJ; Rutkowski P; Powell BWEM; Robert C; Testori A; van Leeuwen BL; van der Veldt AAM; Keilholz U; Stadler R; Eggermont AMM; Verhoef C; Leiter U; Grünhagen DJ
Eur J Cancer; 2020 Jul; 134():9-18. PubMed ID: 32454396
[TBL] [Abstract][Full Text] [Related]
10. A nomogram to predict node positivity in patients with thin melanomas helps inform shared patient decision making.
Friedman C; Lyon M; Torphy RJ; Thieu D; Hosokawa P; Gonzalez R; Lewis KD; Medina TM; Rioth MJ; Robinson WA; Kounalakis N; McCarter MD; Gleisner AL
J Surg Oncol; 2019 Dec; 120(7):1276-1283. PubMed ID: 31602665
[TBL] [Abstract][Full Text] [Related]
11. External validation of the Melanoma Institute Australia Sentinel Node Metastasis Risk Prediction Tool using the National Cancer Database.
Freeman SC; Paz Munoz E; Latour E; Lim JY; Yu W
J Am Acad Dermatol; 2023 Nov; 89(5):967-973. PubMed ID: 37454700
[TBL] [Abstract][Full Text] [Related]
12. External validation in an Australian population of the EORTC-DeCOG nomogram predicting recurrence, distant metastasis and overall mortality in melanoma patients with positive sentinel lymph nodes.
Li AT; Law J; Ch'ng S; Scolyer RA; Thompson JF; Lo SN; Varey AHR
Eur J Cancer; 2023 Aug; 189():112901. PubMed ID: 37263897
[TBL] [Abstract][Full Text] [Related]
13. Comparative validation of online nomograms for predicting nonsentinel lymph node status in sentinel lymph node-positive breast cancer.
Hessman CJ; Naik AM; Kearney NM; Jensen AJ; Diggs BS; Troxell ML; Vetto JT
Arch Surg; 2011 Sep; 146(9):1035-40. PubMed ID: 21931000
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a Brazilian nomogram to assess sentinel node biopsy positivity in melanoma.
Bertolli E; Calsavara VF; de Macedo MP; Pinto CAL; Duprat Neto JP
Tumori; 2021 Oct; 107(5):440-445. PubMed ID: 33143554
[TBL] [Abstract][Full Text] [Related]
15. Validation and head-to-head comparison of three nomograms predicting probability of lymph node invasion of prostate cancer in patients undergoing extended and/or sentinel lymph node dissection.
Grivas N; Wit E; Tillier C; van Muilekom E; Pos F; Winter A; van der Poel H
Eur J Nucl Med Mol Imaging; 2017 Dec; 44(13):2213-2226. PubMed ID: 28780722
[TBL] [Abstract][Full Text] [Related]
16. Assessment of a new scoring system for predicting non-sentinel node positivity in sentinel node-positive melanoma patients.
Wevers KP; Murali R; Bastiaannet E; Scolyer RA; Suurmeijer AJ; Thompson JF; Hoekstra HJ
Eur J Surg Oncol; 2013 Feb; 39(2):179-84. PubMed ID: 23137997
[TBL] [Abstract][Full Text] [Related]
17. Sentinel node biopsy in patients with melanoma improves the accuracy of staging when added to clinicopathological features of the primary tumor.
El Sharouni MA; Stodell MD; Ahmed T; Suijkerbuijk KPM; Cust AE; Witkamp AJ; Sigurdsson V; van Diest PJ; Scolyer RA; Thompson JF; van Gils CH; Lo SN
Ann Oncol; 2021 Mar; 32(3):375-383. PubMed ID: 33253862
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a nomogram to predict recurrence and melanoma-specific mortality in patients with negative sentinel lymph nodes.
Verver D; van Klaveren D; Franke V; van Akkooi ACJ; Rutkowski P; Keilholz U; Eggermont AMM; Nijsten T; Grünhagen DJ; Verhoef C
Br J Surg; 2019 Feb; 106(3):217-225. PubMed ID: 30307046
[TBL] [Abstract][Full Text] [Related]
19. Sentinel lymph node biopsy in patients with thin melanomas: Frequency and predictors of metastasis based on analysis of two large international cohorts.
Isaksson K; Nielsen K; Mikiver R; Nieweg OE; Scolyer RA; Thompson JF; Ingvar C
J Surg Oncol; 2018 Sep; 118(4):599-605. PubMed ID: 30196533
[TBL] [Abstract][Full Text] [Related]
20. A prediction tool incorporating the biomarker S-100B for patient selection for completion lymph node dissection in stage III melanoma.
Damude S; Wevers KP; Murali R; Kruijff S; Hoekstra HJ; Bastiaannet E
Eur J Surg Oncol; 2017 Sep; 43(9):1753-1759. PubMed ID: 28797756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
